Evidence map›Paper›PMID 33532377›Full record

ReviewJournal of family medicine and primary care2020

COVID-19 reinfection: Linked Possibilities and future outlook.

Ekta Krishna, Vineet Kumar Pathak, Reshma Prasad, Hannah Jose, M Mohan Kumar

Open access · goldAbstract readReview
In one paragraph

Review in Journal of family medicine and primary care, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 2 pooled it
0.4field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 2 syntheses or guidelines pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Our Discharge Policy for Novel Coronavirus Infection is Changed.Journal of family medicine and primary care · 2022
    Article
  5. A primer on Post-COVID-19 conditions and implications for clinical pharmacists.Journal of the American College of Clinical Pharmacy : JACCP · 2022
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Viral genome sequencing for Defining Re-infection with COVID-19.Journal of family medicine and primary care · 2021
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Ekta KrishnaDepartment of Community and Family Medicine, All India Institute of Medical Sciences, Raipur, Chhattisgarh, India.
Vineet Kumar PathakDepartment of Community and Family Medicine, All India Institute of Medical Sciences, Raipur, Chhattisgarh, India.
Reshma PrasadDepartment of Community and Family Medicine, All India Institute of Medical Sciences, Raipur, Chhattisgarh, India.
Hannah JoseDepartment of Community and Family Medicine, All India Institute of Medical Sciences, Raipur, Chhattisgarh, India.
M Mohan KumarDepartment of Community and Family Medicine, All India Institute of Medical Sciences, Raipur, Chhattisgarh, India.
All India Institute of Medical Sciences Raipur · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

SARS-CoV-2 is the third major coronavirus epidemic to affect humans. There had been multiple instances of patients turning positive after recovering from SARS-2-CoV infection. Though many different theories emerge, false positive RT-PCR is logically the foremost cause and there is a general consensus that during quarantine re-infection from outside seems unlikely when strictly adhered to. As many new strains emerge worldwide during the course of on-going pandemic, the chances of re-infection cannot be ignored as it may contribute to false negative RT-PCR test results. SARS-2-CoV though a novel virus, is phylogenetically similar to SARS-like CoV with around 79% similarity. Studies on immunological response to these infections suggest that antibodies formed after infection confers immunity only for a short period of time before it starts to wane. Also studies on SARS-CoV-2 suggest that antibody formation and longevity of immunity in an individual is dependent on the strain of coronavirus, its severity and age of the person infected. All these considerations demand reviewing the treatment duration, discharge criteria, appropriate use of imaging techniques and importance of risk communication and health education to those recovered.

Indexed as

AntibodyCovidimmunitypandemicradiological investigationre-infectionSARS

Identifiers

PMID33532377
PMCPMC7842419
OpenAlexW3110204331

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.